Related Experiment Video
Updated: Sep 20, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
The KMT1A/TIMP3/PI3K/AKT circuit regulates tumor growth in cervical cancer
Degui Yang1, Leilei Fan1, Zhenkun Song1
1Department of Gynecology, Shenzhen People's Hospital, Shenzhen 518100, Guangdong, PR China.
Abstract:
The epigenetic mechanism of tissue inhibitor of metalloproteinase 3 (TIMP3), a well-known tumor suppressor, in cervical cancer (CC) is still unclear. Integrated GEO database, protein interaction network, and a pan-cancer analysis revealed a KMT1A/TIMP3 axis in CC. KMT1A was highly expressed, and TIMP3 was poorly expressed in CC tissues and cells. KMT1A inhibited the activity of TIMP3. Silencing of KMT1A hampered the proliferation, migration, invasion, tumorigenesis and metastases of CC cells in vivo, and increased the apoptosis of cells. TIMP3 downregulation promoted the malignant phenotype and in vivo tumorigenesis and metastasis of CC cells. KMT1A downregulation impaired PI3K/AKT pathway in cells, while TIMP3 silencing promoted PI3K/AKT pathway activity. We propose a novel perspective that KMT1A involves in the growth and metastases via the TIMP3/PI3K/AKT axis in CC. In summary, our study identified a vital role played by KMT1A in the development of CC and the epigenetic mechanism, indicating that targeting KMT1A-related pathways could be conducive to the therapies for CC.
Insights
This study uncovers the KMT1A/TIMP3 axis in cervical cancer (CC). Targeting KMT1A may offer new therapeutic strategies for CC by influencing the TIMP3/PI3K/AKT pathway.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Tissue inhibitor of metalloproteinase 3 (TIMP3) is a known tumor suppressor.
- The epigenetic role of TIMP3 in cervical cancer (CC) remains largely unknown.
- Understanding novel regulatory axes is crucial for CC therapeutic development.
Purpose of the Study:
- To elucidate the epigenetic mechanism of TIMP3 in cervical cancer.
- To identify key molecular players and pathways involved in CC development.
- To explore potential therapeutic targets within the identified regulatory axis.
Main Methods:
- Integrated analysis of GEO database and protein interaction networks.
- Pan-cancer analysis to identify the KMT1A/TIMP3 axis.
- In vivo and in vitro experiments assessing cell proliferation, migration, invasion, apoptosis, and tumorigenesis.
- Investigation of the PI3K/AKT signaling pathway.
Main Results:
- A novel KMT1A/TIMP3 axis was identified in cervical cancer.
- KMT1A was highly expressed while TIMP3 was poorly expressed in CC tissues and cells.
- KMT1A inhibition suppressed CC cell proliferation, migration, invasion, tumorigenesis, and metastasis, while promoting apoptosis.
- TIMP3 downregulation enhanced CC malignancy and tumorigenesis.
- KMT1A affected the PI3K/AKT pathway, whereas TIMP3 influenced its activity.
Conclusions:
- KMT1A plays a vital role in cervical cancer development and metastasis through the TIMP3/PI3K/AKT axis.
- Targeting KMT1A-related pathways presents a promising therapeutic strategy for cervical cancer.
- This study provides a novel perspective on the epigenetic regulation in CC progression.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
Abnormal Proliferation

